Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-06-06

Clinical Trial Update: Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia [NA]

View source ↗

Summary

This clinical trial update indicates that ondansetron is being studied to prevent post-dural puncture headaches following spinal anesthesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron (ondansetron)

Snippet

Sponsor: Mongi Slim Hospital | Conditions: Post-Dural Puncture Headache | NA | Status: RECRUITING